Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Codexis Inc (CDXS)

Codexis Inc (CDXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Codexis: Q4 Earnings Snapshot AP - Wed Mar 11, 3:37PM CDT

Codexis: Q4 Earnings Snapshot

CDXS : 1.5800 (-4.82%)
Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results GlobeNewswire - Wed Mar 11, 3:05PM CDT

      Q4 revenue of $38.9 million, total revenue of $70.4 million for the fiscal year ended December 31, 2025 Ended year with $78.2 million in cash, cash equivalents and short-term investments,...

CDXS : 1.5800 (-4.82%)
Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform PR Newswire - Wed Mar 4, 9:06AM CST

REDWOOD CITY, Calif. , March 4, 2026 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...

CDXS : 1.5800 (-4.82%)
Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11 GlobeNewswire - Wed Feb 25, 8:00AM CST

REDWOOD CITY, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today...

CDXS : 1.5800 (-4.82%)
Codexis to Participate in TD Cowen 46th Annual Health Care Conference GlobeNewswire - Tue Feb 17, 8:00AM CST

REDWOOD CITY, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today...

CDXS : 1.5800 (-4.82%)
Codexis Achieves ISO 9001:2015 Certification GlobeNewswire - Tue Feb 10, 8:00AM CST

REDWOOD CITY, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Codexis Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced today that...

CDXS : 1.5800 (-4.82%)
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics PR Newswire - Wed Jan 7, 8:00AM CST

REDWOOD CITY, Calif. , Jan. 7, 2026 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part...

CDXS : 1.5800 (-4.82%)
Codexis Announces Signing of Lease for GMP Manufacturing Facility GlobeNewswire - Mon Nov 10, 2025

REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today...

CDXS : 1.5800 (-4.82%)
Codexis: Q3 Earnings Snapshot AP - Thu Nov 6, 2025

Codexis: Q3 Earnings Snapshot

CDXS : 1.5800 (-4.82%)
Codexis Reports Third Quarter 2025 Financial Results GlobeNewswire - Thu Nov 6, 2025

Announces signing of $37.8m Supply Assurance Agreement with Merck Organizational changes streamline company and reduce operational expenses Cash runway extended through 2027 REDWOOD CITY,...

CDXS : 1.5800 (-4.82%)

Barchart Exclusives

Everyone Is Talking About Volatility. That’s Not The Story. Barchart - Sun Mar 29, 6:00PM CDT
Volatility isn’t the problem. The market is repricing flawed expectations, fragile ownership, and a structural shift investors haven’t caught up to yet. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.